This website uses cookies to enhance the user experience.
21st logo
||
P

PECO AS963 263 201

Limited company
c/o Røyken Legekontor Bråsetveien 10 3440 RØYKEN, Norge

PECO AS

Operating
Å drive helsetjenester og naturlig tilknyttet virksomhet, investering og utleie samt handel med aksjer og verdipapirer, herunder lånefinansierte investeringer med verdipapirer og valuta.
Helsetjenester og naturlig tilknyttet virksomhet, investering og utleie samt handel med aksjer og verdipapirer, herunder lånefinansierte investeringer med verdipapirer og valuta.

Organization

CEO
CS

Christian Steenfeldt-Foss1963

Chairman of the board
CS

Christian Steenfeldt-Foss1963

Years since formation
31 years
since Feb 20, 1995
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
4,770
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2025
5,478,103
NOK
Annual total result 2025
2,909,991
NOK
Total equity 2025
9,861,931
NOK
Last update: Oct 13, 2026

Management

Management / administration

NameRoleShares
CS

Christian Steenfeldt-Foss

1963

Managing Director/CEO-

Board

NameRoleShares
CS

Christian Steenfeldt-Foss

1963

Chairman-
OW

Otto Waldemar Steenfeldt-Foss

1931

Alternate Member-

Others

NameRoleShares
N
NBS ACCOUNTING AS
Accountant-

Top 10 individual shareholders

NameRoleShares
SC

Steenfeldt-Foss Christian

1963

-
100 %
directly
Last update: Sep 26, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
SC

Steenfeldt-Foss Christian

1963

Ordinary shares
4,770
100 %

Shares owned by the PECO AS

NameShare classTotal number of sharesShare
R
RØYKEN LEGEKONTOR AS
Ordinary shares
100
33.33 %
E
ELVIRIA DEL SOL HUS 6 AS
Ordinary shares
190
1.75 %
F
FREEBIT HOLDING AS
Ordinary shares
37,000
0.15 %
P
PICKATALE AS
Ordinary shares
8,721
0.06 %
B
BIOVOTEC AS
Ordinary shares
373
0.03 %
S
SPAREBANK 1 SØR-NORGE ASA
Ordinary shares
300
< 0.01 %
L
LYTIX BIOPHARMA ASA
Ordinary shares
1,558
< 0.01 %
D
DNB BANK ASA
Ordinary shares
200
< 0.01 %
S
STANDARD BIO AS
Ordinary shares
84
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
5,478,103
5,733,382
5,387,623
5,749,767
5,646,156
Annual Total Result
2,909,991
2,693,798
2,165,824
1,553,625
2,719,474
Total assets
12,810,153
10,020,326
9,009,881
7,924,375
6,089,349
Total liabilities
2,948,221
998,385
881,738
1,262,057
980,656
Total equity
9,861,931
9,021,940
8,128,143
6,662,318
5,108,693

P&L

Year20252024202320222021
Total operating income
5,478,103
5,733,382
5,387,623
5,749,767
5,646,156
Total operating costs
2,870,138
2,569,022
2,616,559
3,321,531
2,252,848
Operating result
2,607,965
3,164,360
2,771,064
2,428,237
3,393,308
Financial income/costs
946,849
301,162
50,075
-330,307
83,972
Profit before tax
3,554,814
3,465,522
2,821,139
2,097,929
3,477,280
Total tax & extraordinary income/cost
644,823
771,724
655,315
544,304
757,806
Annual Total Result
2,909,991
2,693,798
2,165,824
1,553,625
2,719,474

Balance overview

Year20252024202320222021
Total fixed assets
7,888,303
5,784,165
6,151,946
5,315,603
3,022,094
Total current assets
4,921,850
4,236,161
2,857,935
2,608,772
3,067,255
Total assets
12,810,153
10,020,326
9,009,881
7,924,375
6,089,349
Short term debt
2,932,795
976,555
841,690
1,228,037
963,618
Long term debt
15,426
21,830
40,049
34,020
17,038
Total liabilities
2,948,221
998,385
881,738
1,262,057
980,656
Contributed capital
477,000
477,000
477,000
477,000
477,000
Retained earnings
9,384,931
8,544,940
7,651,143
6,185,318
4,631,693
Total equity
9,861,931
9,021,940
8,128,143
6,662,318
5,108,693
Total equity and liabilities
12,810,153
10,020,326
9,009,881
7,924,375
6,089,349

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification